Support that is Accelerating Neurofibromatosis type 1 (NF1) Research

With nearly $60 million awarded to more than 80 investigators around the world in the past decade, NTAP is changing the field. NTAP grants come with more than money: Successful applicants gain a network of top advisors including NTAP staff and our many external partners. You may be invited to join a consortium and/or attend virtual and in-person meetings with others working in the same research area, who may enrich or even partner on your project.

Research Funds Committed through 2023

Row triangle Shape Decorative svg added to top

Focusing on therapeutics: Scientific initiatives through 2023

 

Focusing on therapeutics: Across the continuum of discovery to clinical science

These funds have supported a range of products focused on cutaneous and plexiform neurofibromas, growing the field of NF1 investigators and accelerating NF1 tumor-associated research through critical research tools. Learn more about NTAP-funded initiatives here.